Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Alar Announces Significant Progress on Developing Long-acting Buprenorphine Injectable ALA-1000 2022-01-13 00:00
Breaking the Cycle of Opioid Addiction: Alar Presents Positive Interim Results of Long-acting Buprenorphine Injectable (ALA-1000) in Opioid Dependent Patients 2021-03-10 00:00
1